Ignite Creation Date:
2024-07-17 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498518
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-02
Brief Title:
A Trial of Gemcitabine Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor:
Karen Carty
Organization:
University of Glasgow
Organization Data
Organization:
University of Glasgow
Class:
OTHER
Study ID:
PRIMUS006-2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Karen Carty
Lead Sponsor Class:
OTHER
Responsible Party:
Karen Carty
Responsible Party Title:
Mrs
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Glasgow
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| NHS Greater Glasgow and Clyde | OTHER |
| University of Glasgow | OTHER |